Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Buildings: 2011-2022

Historic Buildings for China Pharma Holdings (CPHI) over the last 12 years, with Dec 2022 value amounting to $9.4 million.

  • China Pharma Holdings' Buildings fell 7.12% to $9.1 million in Q2 2023 from the same period last year, while for Jun 2023 it was $9.1 million, marking a year-over-year decrease of 7.12%. This contributed to the annual value of $9.4 million for FY2022, which is 8.46% down from last year.
  • As of FY2022, China Pharma Holdings' Buildings stood at $9.4 million, which was down 8.46% from $10.3 million recorded in FY2021.
  • In the past 5 years, China Pharma Holdings' Buildings registered a high of $10.3 million during FY2021, and its lowest value of $9.4 million during FY2019.
  • Its 3-year average for Buildings is $9.9 million, with a median of $10.0 million in 2020.
  • Per our database at Business Quant, China Pharma Holdings' Buildings increased by 6.92% in 2020 and then decreased by 8.46% in 2022.
  • Over the past 5 years, China Pharma Holdings' Buildings (Yearly) stood at $9.5 million in 2018, then declined by 1.43% to $9.4 million in 2019, then rose by 6.92% to $10.0 million in 2020, then rose by 2.34% to $10.3 million in 2021, then dropped by 8.46% to $9.4 million in 2022.